UnitedHealth Group Incorporated (NYSE:UNH) saw an upside of 1.19% to close Tuesday at $491.60 after adding $5.79 on the day. The 5-day average trading volume is 3,785,660 shares of the company’s common stock. It has gained $500.26 in the past week and touched a new high 3 times within the past 5 days. An average of 3,521,415 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,475,458.
UNH’s 1-month performance is -6.81% or -$39.71 on its low of $474.75 reached on 01/18/23. The company’s shares have touched a 52-week low of $445.73 and high of $558.10, with the stock’s rally to the 52-week high happening on 01/03/23. YTD, UNH has lost -7.28% or -$38.58 and has reached a new high 1 time. However, the current price is down -11.92% from the 52-week high price.
UNH stock investors last saw insider trading activity on Dec 07.McSweeney Erin (EVP Chief People Officer) most recently sold 450 shares at $542.30 per share on Dec 07. This transaction cost the insider $244,035. EVP Chief People Officer, McSweeney Erin, sold 616 shares at a price of $535.00 on Dec 02. Then, on Aug 26, Chief Accounting Officer ROOS THOMAS E sold 465 shares at a price of $542.37 per share. This transaction amounted to $252,201.
UNH stock has a beta of 0.72. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.41 while the price-to-book (PB) in the most recent quarter is 6.16, with the price to cash flow ratio at 30.86.
As well, the company’s long term debt to equity for the quarter ending December 30 was 0.61, while the total debt to equity was 0.65. The firm’s gross profit as reported stood at $79.62 billion against revenue of $324.16 billion.
For the quarterly period ending December 30 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 22.35% to $5.26 billion, while revenue of $5.07 billion was 3.65% off the previous quarter. Analysts expected UNH to announce $5.17 per share in earnings in its latest quarter, but it posted $5.34, representing a 3.30% surprise. UNH stock balance sheet for the quarter ending December 30 shows that total liabilities totaled 164.25 billion, with total debt at $57.62 billion.
Let’s look briefly at UnitedHealth Group Incorporated (UNH) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 44.55% to suggest the stock is trending Neutral, with historical volatility in this time period at 18.79%.
The stock’s 5-day moving average is $484.95, reflecting a +1.34% or $6.52 change from its current price. UNH is currently trading -6.73% above its 20-day SMA, -5.98% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -9.07% and SMA200 by-7.55%.
Stochastic %K and %D was 27.20% and 20.14% and the average true range (ATR) pointed at 12.19. The RSI (14) points at 41.35%, while the 14-day stochastic is at 38.39% with the period’s ATR at 11.82. The stock’s 9-day MACD Oscillator is pointing at 0.44 and -1.17 on the 14-day charts.
What is UNH’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $480.00 and a high of $650.00, with their median price target at $600.00. Looking at these predictions, the average price target given by analysts is for UnitedHealth Group Incorporated (UNH) stock is $594.83.